SKN | Belgian Fibrotic Disease Biotech AgomAb Therapeutics Sets Terms for $200 Million US IPO
AgomAb Therapeutics, a Belgian biotechnology company developing treatments for fibrotic diseases, has set terms for a planned $200 million initial public offering in the...
SKN | Seagate Shares Hit Record High as AI Storage Boom Drives Earnings Re-Rating
Seagate Technology Holdings plc surged to an all-time high following a strong quarterly earnings report that reinforced investor confidence in the company’s exposure to...
SKN | Hair Loss Biotech Veradermics Sets Terms for $200 Million IPO
Veradermics, a clinical-stage biotechnology company focused on treatments for hair loss and dermatological conditions, has set terms for a $200 million initial public offering...
SKN | Tetra Tech Slides Ahead of Q1 Earnings as Investors Weigh Growth Outlook
Tetra Tech, Inc. shares traded lower in early market action as investors positioned cautiously ahead of the company’s first-quarter fiscal 2026 earnings release. The...
SKN | QT Imaging Holdings Jumps as Speculative Interest Returns to Medical Imaging Play
Stock Performance Snapshot
Shares of QT Imaging Holdings, Inc. closed at $0.3951 on November 25, marking a sharp single-session gain after previously trading near zero....